BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eriksson KS, Sergeeva OA, Haas HL, Selbach O. Orexins/hypocretins and aminergic systems. Acta Physiol (Oxf) 2010;198:263-75. [PMID: 19566795 DOI: 10.1111/j.1748-1716.2009.02015.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Rainero I, Ostacoli L, Rubino E, Gallone S, Rocco Picci L, Fenoglio P, Negro E, Rosso C, De Martino P, De Marchi M, Furlan PM, Pinessi L. Association between Major Mood Disorders and the hypocretin receptor 1 gene. Journal of Affective Disorders 2011;130:487-91. [DOI: 10.1016/j.jad.2010.10.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
2 Zhang H, Lian Z, Yan S, Bao Y, Liu Z. Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities. Biomed Res Int 2013;2013:282641. [PMID: 24102051 DOI: 10.1155/2013/282641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Larhammar M, Patra K, Blunder M, Emilsson L, Peuckert C, Arvidsson E, Rönnlund D, Preobraschenski J, Birgner C, Limbach C, Widengren J, Blom H, Jahn R, Wallén-Mackenzie Å, Kullander K. SLC10A4 is a vesicular amine-associated transporter modulating dopamine homeostasis. Biol Psychiatry 2015;77:526-36. [PMID: 25176177 DOI: 10.1016/j.biopsych.2014.07.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
4 Shahsavari F, Abbasnejad M, Raoof M, Esmaeili-Mahani S. The rostral ventromedial medulla orexin 1 receptors and extracellular signal-regulated kinase in hippocampus are involved in modulation of anxiety behavior induced by dental pulp nociception in adult male rats. Arch Oral Biol 2020;116:104778. [PMID: 32474210 DOI: 10.1016/j.archoralbio.2020.104778] [Reference Citation Analysis]
5 Belle MD, Hughes AT, Bechtold DA, Cunningham P, Pierucci M, Burdakov D, Piggins HD. Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock. J Neurosci 2014;34:3607-21. [PMID: 24599460 DOI: 10.1523/JNEUROSCI.3388-13.2014] [Cited by in Crossref: 81] [Cited by in F6Publishing: 34] [Article Influence: 10.1] [Reference Citation Analysis]
6 Pagano G, Politis M. Molecular Imaging of the Serotonergic System in Parkinson's Disease. Imaging in Movement Disorders: Imaging Methodology and Applications in Parkinson's Disease. Elsevier; 2018. pp. 173-210. [DOI: 10.1016/bs.irn.2018.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
7 Puskás N, Papp RS, Gallatz K, Palkovits M. Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides 2010;31:1589-97. [PMID: 20434498 DOI: 10.1016/j.peptides.2010.04.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yang L, Zou B, Xiong X, Pascual C, Xie J, Malik A, Xie J, Sakurai T, Xie XS. Hypocretin/orexin neurons contribute to hippocampus-dependent social memory and synaptic plasticity in mice. J Neurosci 2013;33:5275-84. [PMID: 23516292 DOI: 10.1523/JNEUROSCI.3200-12.2013] [Cited by in Crossref: 77] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
9 Volkoff H. Sleep and Orexins in Nonmammalian Vertebrates. Sleep Hormones. Elsevier; 2012. pp. 315-39. [DOI: 10.1016/b978-0-12-394623-2.00017-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
10 Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 2012;37:1224-33. [PMID: 22237311 DOI: 10.1038/npp.2011.310] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
11 von Gall C. The Effects of Light and the Circadian System on Rhythmic Brain Function. Int J Mol Sci 2022;23:2778. [PMID: 35269920 DOI: 10.3390/ijms23052778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ardeshiri MR, Hosseinmardi N, Akbari E. Orexin 1 and orexin 2 receptor antagonism in the basolateral amygdala modulate long-term potentiation of the population spike in the perforant path-dentate gyrus-evoked field potential in rats. Neurobiology of Learning and Memory 2018;149:98-106. [DOI: 10.1016/j.nlm.2018.02.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Krainin J, Morrison AA, Russo MB. Sleep/Wake Disturbances in Mild Traumatic Brain Injury Patients. In: Tsao JW, editor. Traumatic Brain Injury. Cham: Springer International Publishing; 2020. pp. 129-50. [DOI: 10.1007/978-3-030-22436-3_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kistner A, Lhommée E, Krack P. Mechanisms of body weight fluctuations in Parkinson's disease. Front Neurol 2014;5:84. [PMID: 24917848 DOI: 10.3389/fneur.2014.00084] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
15 Penney CC, Volkoff H. Peripheral injections of cholecystokinin, apelin, ghrelin and orexin in cavefish (Astyanax fasciatus mexicanus): effects on feeding and on the brain expression levels of tyrosine hydroxylase, mechanistic target of rapamycin and appetite-related hormones. Gen Comp Endocrinol 2014;196:34-40. [PMID: 24287340 DOI: 10.1016/j.ygcen.2013.11.015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
16 Berrendero F, Flores Á, Robledo P. When orexins meet cannabinoids: Bidirectional functional interactions. Biochemical Pharmacology 2018;157:43-50. [DOI: 10.1016/j.bcp.2018.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Flores A, Maldonado R, Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 2013;7:256. [PMID: 24391536 DOI: 10.3389/fnins.2013.00256] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
18 Mlyczyńska E, Kieżun M, Kurowska P, Dawid M, Pich K, Respekta N, Daudon M, Rytelewska E, Dobrzyń K, Kamińska B, Kamiński T, Smolińska N, Dupont J, Rak A. New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides. Cells 2022;11:957. [DOI: 10.3390/cells11060957] [Reference Citation Analysis]
19 Farahmandfar M, Kadivar M, Rastipisheh S. Blockade of dorsal hippocampal orexin-1 receptors impaired morphine-induced state-dependent learning. Neuropeptides 2016;60:13-9. [DOI: 10.1016/j.npep.2016.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lin JS, Anaclet C, Sergeeva OA, Haas HL. The waking brain: an update. Cell Mol Life Sci 2011;68:2499-512. [PMID: 21318261 DOI: 10.1007/s00018-011-0631-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
21 Clarke RE, Verdejo-Garcia A, Andrews ZB. The role of corticostriatal-hypothalamic neural circuits in feeding behaviour: implications for obesity. J Neurochem 2018;147:715-29. [PMID: 29704424 DOI: 10.1111/jnc.14455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
22 Hoever P, Dorffner G, Beneš H, Penzel T, Danker-Hopfe H, Barbanoj MJ, Pillar G, Saletu B, Polo O, Kunz D, Zeitlhofer J, Berg S, Partinen M, Bassetti CL, Högl B, Ebrahim IO, Holsboer-Trachsler E, Bengtsson H, Peker Y, Hemmeter UM, Chiossi E, Hajak G, Dingemanse J. Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clin Pharmacol Ther 2012;91:975-85. [PMID: 22549286 DOI: 10.1038/clpt.2011.370] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 9.3] [Reference Citation Analysis]
23 Cho CH, Lee HJ, Woo HG, Choi JH, Greenwood TA, Kelsoe JR. CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis. Psychiatry Investig 2015;12:402-7. [PMID: 26207136 DOI: 10.4306/pi.2015.12.3.402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yu L, Zhang XY, Zhang J, Zhu JN, Wang JJ. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro. Cerebellum 2010;9:88-95. [PMID: 19921532 DOI: 10.1007/s12311-009-0146-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
25 Ruan HZ, Wang LQ, Yuan F, Weng SJ, Zhong YM. Orexin-A differentially modulates inhibitory and excitatory synaptic transmission in rat inner retina. Neuropharmacology 2021;187:108492. [PMID: 33582153 DOI: 10.1016/j.neuropharm.2021.108492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]